Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

Healthcare Biotechnology
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines... see more

Current News (CSE:MDMA)

PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital

GlobeNewswire 13 days ago

CSE Bulletin: MOC Eligibility Update

Newsfile October 16, 2025

PharmAla Launches Nexus Portal for MDMA Prescribers and Therapists

GlobeNewswire October 8, 2025

PharmAla Completes Shipment of LaNeo(TM) MDMA to Johns Hopkins

GlobeNewswire October 2, 2025

PharmAla Partners with Veridion Group as Exclusive Distributor in New Zealand

GlobeNewswire September 25, 2025

PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus

GlobeNewswire September 19, 2025

PharmAla Completes Import of LaNeo MDMA for US Distribution

GlobeNewswire September 8, 2025

PharmAla Incorporates Australian Entity for Clinical Research

GlobeNewswire September 3, 2025

PharmAla Delivers MDMA to Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License

GlobeNewswire August 7, 2025
View More News ››

Opinion & Analysis (CSE:MDMA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:MDMA)

A Clear Disconnect from the Retail base

Is a massive understatement. best to ignore the stats and so called accomplishments that do include shareholders here and ceo.ca who for...
Charleyfarley - 5 days ago

12 Million Dollar market Cap

Hitting a nerve that triggers more Insults  is all I see here and it accomplishes nothing -  Nothing would give me the the...
Charleyfarley - 5 days ago

PharmAla

So I thought I would revisit the statement below that our resident fool, Charley, made about lack of evidence and proof-of-concept, to...
inviolablspirit - 5 days ago

RE:Clinical Trial Data

The original post to link was by @07fintech10 and my response is for @TradesWhenDrunk
inviolablspirit - 6 days ago

Clinical Trial Data

I was just reading some of the comments on ceo.ca and clicked on the following link by one poster: MDMA-Assisted Psychotherapy for...
inviolablspirit - 6 days ago

RE:RE:RE:LADIES AND GENTLEMEN

Oops!  I think I broke Charlie's brain.  Sorry guys!  I wasn't expecting him to respond with three consecutive...
inviolablspirit - 6 days ago
View more Bullboard ››

Fineqia International Inc.

Fineqia International Inc.

Publicly listed in Canada (CSE: FNQ) with quoted symbols on Nasdaq (OTC: FNQQF) and the Frankfurt Stock Exchange (Frankfurt ...
View More »